Please use this identifier to cite or link to this item:
Title: Integrative genomics identifies RAB23 as an invasion mediator gene in diffuse-type gastric cancer
Authors: Hou, Q.
Yong, H.W.
Grabsch, H.
Zhu, Y.
Siew, H.L.
Ganesan, K.
Cross, D.
Lay, K.T.
Tao, J.
Gopalakrishnan, V.
Bor, L.T. 
Oi, L.K. 
Tan, P. 
Issue Date: 15-Jun-2008
Citation: Hou, Q., Yong, H.W., Grabsch, H., Zhu, Y., Siew, H.L., Ganesan, K., Cross, D., Lay, K.T., Tao, J., Gopalakrishnan, V., Bor, L.T., Oi, L.K., Tan, P. (2008-06-15). Integrative genomics identifies RAB23 as an invasion mediator gene in diffuse-type gastric cancer. Cancer Research 68 (12) : 4623-4630. ScholarBank@NUS Repository.
Abstract: Recurrent genomic amplifications and deletions are frequently observed in primary gastric cancers (GC). However, identifying specific oncogenes and tumor suppressor genes within these regions can be challenging, as they often cover tens to hundreds of genes. Here, we combined high-resolution array-based comparative genomic hybridization (aCGH) with gene expression profiling to target genes within focal high-level amplifications in GC cell lines, and identified RAB23 as an amplified and overexpressed Chr 6p11p12 gene in Hs746T cells. High RAB23 protein expression was also observed in some lines lacking RAB23 amplification, suggesting additional mechanisms for up-regulating RAB23 besides gene amplification. siRNA silencing of RAB23 significantly reduced cellular invasion and migration in Hs746T cells, whereas overexpression of RAB23 enhanced cellular invasion in AGS cells. RAB23 amplifications in primary gastric tumors were confirmed by both fluorescence in situ hybridization and genomic qPCR, and in two independent patient cohorts from Hong Kong and the United Kingdom RAB23 expression was significantly associated with diffuse-type GC (dGC) compared with intestinal-type GC (iGC). These results provide further evidence that dGC and iGC likely represent two molecularly distinct tumor types, and show that investigating focal chromosomal amplifications by combining high-resolution aCGH with expression profiling is a powerful strategy for identifying novel cancer genes in regions of recurrent chromosomal aberration. ©2008 American Association for Cancer Research.
Source Title: Cancer Research
ISSN: 00085472
DOI: 10.1158/0008-5472.CAN-07-5870
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.


checked on Jan 31, 2023


checked on Jan 31, 2023

Page view(s)

checked on Jan 26, 2023

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.